Log In
BCIQ
Print this Print this
 

Gilotrif, Giotrif, afatinib (Tomtovok) (BIBW 2992)

Also known as: Tovok

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionTyrosine kinase inhibitor (TKI) that binds the kinase domains of EGFR1, HER2 and EGFR4
Molecular Target Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1) ; Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/08/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today